Manager TitleAgeSince
Chief Executive Officer 49 30/05/2025
Director of Finance/CFO 61 30/05/2025
Sales & Marketing 53 31/12/2023
Director TitleAgeSince
Director/Board Member 62 31/12/2019
Chairman 42 31/05/2025
Director/Board Member 75 31/05/2025
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
-2.20%-2.48%-15.20%+7.08% 197B
-2.23%-4.42%-2.40%+9.47% 118B
-2.00%+1.30%+10.88%+78.98% 62.55B
-2.00%-3.74%+27.02%+53.48% 52.4B
-1.09%+0.28%-3.06%-32.81% 51.81B
+0.37%-0.66%+17.30%-11.38% 33.57B
+0.20%+2.18% - - 30.34B
-1.09%-1.90%+41.55%-12.10% 24.63B
-0.47%+3.56%-3.25%+19.21% 23.81B
Average -4.37%+0.67%+9.11%+13.99% 66.04B
Weighted average by Cap. -1.35%+0.01%+0.32%+14.78%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock